Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance

NCT02975128 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02975128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02975128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
February 19, 2018
Completion date
July 31, 2019
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breastcancer